Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake

Journal of Pharmaceutical Sciences

Volumn 98, Issue 10, 2009, Pages 3640-3646

  Vaka, Siva Ram Kiran ^a   Sammeta, S M ^a   Day, Lainy B ^a   Murthy, S Narasimha ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Bioavailability; Chitosan; Microdialysis; Nerve growth factor; Nose to brain; Targeting

Indexed keywords

CHITOSAN; NERVE GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG PENETRATION; ELECTRIC RESISTANCE; HIPPOCAMPUS; IN VITRO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MICRODIALYSIS; NONHUMAN; OLFACTORY EPITHELIUM; RAT;

EID: 70349254016     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21674     Document Type: Article

References (30)

1. Thorne RG, Frey WH. 2001. Delivery of neurotrophic factors to the central nervous system. Pharmacokinetic considerations. Clin Pharmacokinet 40:907-946.
2. Kordower JH, Palfi S, Chen EY. 1999. Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Ann Neurol 46:419-424. (Pubitemid 29416283)
3. Hanson LR, Frey WH, II. 2007. Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS. J Neuroimmune Pharmacol 2:81-86.
4. Shilpley MT. 1985. Transport of molecules from nose to brain: Transneuronal anterograde and retrograde labeling in the rat olfactory system by wheat germ agglutinin-horseradish peroxidase applied to the nasal epithelium. Brain Res Bull 15:129-142.
5. Barnett EM, Perlman S. 1993. The olfactory nerve and not the trigeminal nerve is the major site of CNS entry for mouse hepatitis virus, strain JHM. Virology 94:185-191. (Pubitemid 23211751)
6. Baker H, Spencer RF. 1986. Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat. Exp Brain Res 63:461-473. (Pubitemid 16036221)
7. Martinez HJ, Dreyfus CF, Jonakait GM, Black IB. 1985. Nerve growth factor promotes cholinergic development in brain striatal cultures. Neurobiology 82:7777-7781.
8. 125I-NGF to the brain via the olfactory route. Drug Deliv 4:87-92.
9. Chen X, Fawett JR, Rahman Y, Ala TA, Frey WH. 1998. Delivery of nerve growth factor to the brain via the olfactory pathway. J Alzheimer's Dis 1:35-44. (Pubitemid 30832306)
10. Illium L, Farraj NF, Davis SS. 1994. Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res 11:1186-1189.
11. Illium L. 2003. Nasal drug delivery: Possibilities, problems and solutions. J Control Release 87:187-198. (Pubitemid 36255456)
12. Tengamnuay P, Sahamethapat A, Sailasuta A, Mitra AK. 2000. Chitosan as nasal absorption enhancers of peptides: Comparison between free amine chitosans and soluble salts. Int J Pharm 197:53-67. (Pubitemid 30125777)
13. Lubben I, Verhoef JC, Borchard G, Junginger HE. 2001. Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur J Pharm Sci 14:201-207. (Pubitemid 32884316)
14. Yao J, Zhou JP, Ping QN, Lu Y, Chen L. 2009. Distribution of nobiletin chitosan-based microemulsions in brain following i.v. injection in mice. Int J Pharm 352:256-262. (Pubitemid 351273917)
15. Hu Y, Ding Y, Ding D, Sun M, Zhang L, Jiang X, Yang C. 2007. Hollow chitosan/poly(acrylic acid) nanospheres as drug carriers. Biomacromolecules 8:1069-1076. (Pubitemid 46672682)
16. Dodane V, Khan MA, Merwin J. 1999. Effect of chitosan on Caco-2 on epithelial permeability and structure. Int J Pharm 182:21-32. (Pubitemid 29229791)
17. Sosnik A, Carcaboso AM, Chiappetta DA. 2009. Polymeric nanocarriers: New endeavors for the optimization of the technological aspects of drugs. Recent Patents Biomed Eng 1:43-59.
18. Werle M, Hoffer M. 2006. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J Control Release 111:41-46. (Pubitemid 43289993)
19. Schmidt MC, Simmen D, Hilbe M, Boderke P, Ditzinger G, Sandow J, Lang S, Rubas W, Merkle HP. 2000. Validation of excised bovine nasal mucosa as in vitro model to study drug transport and metabolic pathways in nasal epithelium. J Pharm Sci 89:396-407. (Pubitemid 30152439)
20. Krewson CE, Klarman ML, Saltzman WM. 1995. Distribution of nerve growth factor following direct delivery to brain interstitium. Brain Res 680:196-206.
21. Lapchak PA, Hefti F. 1991. Emerging pharmacology of nerve growth factor. Prog Neuro-Psychopharmacol Biol Psychiatry 15:851-860.
22. Narai A, Arai S, Shimizu M. 1997. Rapid decrease in transepithelial electrical resistance of human intestinal Caco-2 cell monolayers by cytotoxic membrane perturbents. Toxicol In Vitro 11:347-354. (Pubitemid 27368258)
23. Smith J, Wood E, Dornish M. 2004. Effect of chitosan on epithelial cell tight junctions. Pharm Res 21:43-49. (Pubitemid 38122290)
24. Young AM. 1993. Intracerebral microdialysis in the study of physiology and behavior. Rev Neurosci 4:373-395.
25. Westerink BH. 1995. Brain microdialysis and its application for the study of animal behaviour. Behav Brain Res 70:103-124.
26. Mas M, Gonzalez-mora JL, Hernandez L. 1996. In vivo monitoring of brain neurotransmitter release for the assessment of neuroendocrine interactions. Cell Mol Neurobiol 16:383-396.
27. Bradberry CW. 2000. Applications of microdialysis methodology in nonhuman primates: Practice and rationale. Crit Rev Neurobiol 14:143-163.
28. Chang Q, Savage LM, Gold PE. 2006. Microdialysis measures of functional increases in Ach release in the hippocampus with and without inclusion of acetylcholinesterase inhibitors in the perfusate. J Neurochem 97:697-706.
29. Honer MC, Hewitt E, Conner JM, Costello JW, Varon S. 1996. Nerve growth factor content in adult rat brain tissue is several-fold higher than generally reported and is largely associated with sedimentable fractions. Brain Res 728:47-56. (Pubitemid 26254955)
30. Fawcett JR, Chen X, Rahaman Y, Frey WH. 1999. Previously reported nerve growth factor levels are underestimated due to an incomplete release from receptors and interaction with standard curve media. Brain Res 842:206-210. (Pubitemid 29447868)